Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spasms, Infantile | 9 | 2023 | 305 | 1.470 |
Why?
|
Models, Statistical | 6 | 2021 | 5102 | 1.250 |
Why?
|
Epilepsy | 14 | 2023 | 3310 | 1.020 |
Why?
|
China | 13 | 2024 | 2247 | 0.860 |
Why?
|
Device Approval | 1 | 2022 | 163 | 0.730 |
Why?
|
Likelihood Functions | 4 | 2017 | 1005 | 0.660 |
Why?
|
Spastic Paraplegia, Hereditary | 3 | 2023 | 157 | 0.560 |
Why?
|
Research Subjects | 1 | 2018 | 239 | 0.560 |
Why?
|
Linear Models | 7 | 2023 | 5953 | 0.560 |
Why?
|
Statistics, Nonparametric | 4 | 2018 | 2886 | 0.540 |
Why?
|
Health Expenditures | 2 | 2018 | 2348 | 0.500 |
Why?
|
Models, Economic | 1 | 2018 | 713 | 0.470 |
Why?
|
Neuroblastoma | 1 | 2022 | 1226 | 0.470 |
Why?
|
Cluster Analysis | 3 | 2023 | 2715 | 0.470 |
Why?
|
Central Nervous System Neoplasms | 1 | 2022 | 895 | 0.460 |
Why?
|
Hearing Loss | 1 | 2021 | 765 | 0.450 |
Why?
|
Depression | 7 | 2024 | 7767 | 0.440 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 7908 | 0.440 |
Why?
|
Models, Theoretical | 2 | 2023 | 3591 | 0.430 |
Why?
|
Spasm | 8 | 2023 | 121 | 0.430 |
Why?
|
Hypoparathyroidism | 3 | 2021 | 120 | 0.430 |
Why?
|
Status Epilepticus | 3 | 2023 | 444 | 0.430 |
Why?
|
Computer Simulation | 8 | 2023 | 6196 | 0.420 |
Why?
|
Seizures | 13 | 2023 | 2859 | 0.400 |
Why?
|
Cesarean Section | 1 | 2019 | 1365 | 0.380 |
Why?
|
Endometriosis | 4 | 2012 | 839 | 0.370 |
Why?
|
Longitudinal Studies | 8 | 2023 | 13990 | 0.350 |
Why?
|
Data Interpretation, Statistical | 3 | 2019 | 2715 | 0.350 |
Why?
|
Intensive Care Units | 1 | 2023 | 3680 | 0.350 |
Why?
|
Professional Competence | 1 | 2012 | 448 | 0.340 |
Why?
|
Electroencephalography | 13 | 2023 | 6150 | 0.340 |
Why?
|
Algorithms | 6 | 2023 | 13885 | 0.310 |
Why?
|
Cerebral Palsy | 2 | 2022 | 459 | 0.300 |
Why?
|
Humans | 91 | 2024 | 744220 | 0.290 |
Why?
|
Vigabatrin | 3 | 2023 | 92 | 0.290 |
Why?
|
Health Policy | 1 | 2019 | 2661 | 0.290 |
Why?
|
Research Design | 3 | 2019 | 5987 | 0.280 |
Why?
|
Biostatistics | 3 | 2019 | 162 | 0.270 |
Why?
|
Diagnostic Errors | 1 | 2012 | 1255 | 0.260 |
Why?
|
Child | 32 | 2024 | 77679 | 0.260 |
Why?
|
Anticonvulsants | 7 | 2023 | 1917 | 0.250 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.250 |
Why?
|
Tuberous Sclerosis | 2 | 2023 | 1029 | 0.250 |
Why?
|
Brain Diseases | 2 | 2023 | 1564 | 0.240 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5755 | 0.230 |
Why?
|
Opsoclonus-Myoclonus Syndrome | 1 | 2023 | 8 | 0.230 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.220 |
Why?
|
Adaptor Protein Complex 4 | 1 | 2023 | 38 | 0.220 |
Why?
|
Schools | 4 | 2024 | 1433 | 0.220 |
Why?
|
Electronic Health Records | 1 | 2019 | 4463 | 0.220 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2022 | 42 | 0.210 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2022 | 39 | 0.210 |
Why?
|
Myelitis | 1 | 2022 | 53 | 0.210 |
Why?
|
Marriage | 1 | 2024 | 339 | 0.210 |
Why?
|
Enterovirus Infections | 1 | 2022 | 72 | 0.210 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2022 | 111 | 0.200 |
Why?
|
Pentylenetetrazole | 1 | 2021 | 69 | 0.200 |
Why?
|
Convulsants | 1 | 2021 | 70 | 0.200 |
Why?
|
Female | 47 | 2024 | 380197 | 0.200 |
Why?
|
Parathyroid Hormone | 3 | 2021 | 1801 | 0.200 |
Why?
|
Myasthenic Syndromes, Congenital | 1 | 2021 | 18 | 0.190 |
Why?
|
Malaria, Cerebral | 1 | 2022 | 135 | 0.190 |
Why?
|
Adrenocorticotropic Hormone | 4 | 2023 | 648 | 0.190 |
Why?
|
Health Behavior | 3 | 2023 | 2636 | 0.190 |
Why?
|
Alcoholic Beverages | 1 | 2022 | 265 | 0.190 |
Why?
|
Cytoplasmic Dyneins | 1 | 2020 | 25 | 0.190 |
Why?
|
Mental Health | 3 | 2023 | 3019 | 0.190 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 25043 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 9960 | 0.180 |
Why?
|
Movement Disorders | 1 | 2023 | 445 | 0.180 |
Why?
|
Neuromuscular Diseases | 1 | 2022 | 253 | 0.180 |
Why?
|
Male | 39 | 2024 | 350027 | 0.180 |
Why?
|
Probability | 2 | 2023 | 2505 | 0.170 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2020 | 98 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 326 | 0.170 |
Why?
|
Unsafe Sex | 2 | 2018 | 220 | 0.170 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 260 | 0.170 |
Why?
|
Galvanic Skin Response | 1 | 2021 | 349 | 0.170 |
Why?
|
Ancylostomiasis | 1 | 2018 | 5 | 0.170 |
Why?
|
Ancylostoma | 1 | 2018 | 10 | 0.160 |
Why?
|
Myasthenia Gravis | 1 | 2021 | 201 | 0.160 |
Why?
|
Adolescent | 19 | 2024 | 85759 | 0.160 |
Why?
|
Social Isolation | 1 | 2021 | 365 | 0.160 |
Why?
|
Chromosome Disorders | 1 | 2021 | 515 | 0.160 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2018 | 66 | 0.160 |
Why?
|
Hemolysin Proteins | 1 | 2018 | 113 | 0.160 |
Why?
|
Nicotinic Antagonists | 1 | 2018 | 96 | 0.160 |
Why?
|
Therapies, Investigational | 1 | 2019 | 112 | 0.160 |
Why?
|
Anthelmintics | 1 | 2018 | 62 | 0.160 |
Why?
|
Rural Population | 4 | 2023 | 2210 | 0.160 |
Why?
|
Muscle Weakness | 1 | 2021 | 415 | 0.160 |
Why?
|
Sample Size | 2 | 2019 | 846 | 0.150 |
Why?
|
Melatonin | 1 | 2023 | 721 | 0.150 |
Why?
|
Bullying | 1 | 2020 | 210 | 0.150 |
Why?
|
Vision Disorders | 2 | 2023 | 1059 | 0.150 |
Why?
|
Epilepsies, Partial | 1 | 2021 | 436 | 0.150 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2020 | 259 | 0.140 |
Why?
|
SEER Program | 1 | 2022 | 1508 | 0.140 |
Why?
|
Equipment and Supplies | 1 | 2019 | 281 | 0.140 |
Why?
|
Chromosome Deletion | 1 | 2021 | 1401 | 0.140 |
Why?
|
Alcohol Drinking | 2 | 2022 | 3966 | 0.140 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2023 | 4266 | 0.140 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2022 | 852 | 0.140 |
Why?
|
Parturition | 1 | 2019 | 441 | 0.130 |
Why?
|
Endotoxins | 1 | 2018 | 527 | 0.130 |
Why?
|
Cross-Over Studies | 2 | 2019 | 2032 | 0.130 |
Why?
|
Biometry | 1 | 2018 | 558 | 0.130 |
Why?
|
Pandemics | 7 | 2023 | 8387 | 0.130 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 372 | 0.130 |
Why?
|
Behavior, Addictive | 1 | 2020 | 462 | 0.130 |
Why?
|
Toxicity Tests | 1 | 2015 | 121 | 0.130 |
Why?
|
Ethylene Glycols | 1 | 2015 | 156 | 0.120 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1583 | 0.120 |
Why?
|
Social Support | 2 | 2023 | 2117 | 0.120 |
Why?
|
Aged | 11 | 2023 | 163253 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2023 | 2969 | 0.120 |
Why?
|
Vitamin E Deficiency | 1 | 2013 | 32 | 0.120 |
Why?
|
Child, Preschool | 11 | 2023 | 40992 | 0.120 |
Why?
|
Methyl Ethers | 1 | 2015 | 205 | 0.120 |
Why?
|
Caenorhabditis elegans | 1 | 2022 | 1420 | 0.120 |
Why?
|
Infant | 10 | 2023 | 35129 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2023 | 2050 | 0.110 |
Why?
|
Retrospective Studies | 16 | 2023 | 77426 | 0.110 |
Why?
|
United States | 6 | 2023 | 69867 | 0.110 |
Why?
|
alpha-Tocopherol | 1 | 2013 | 127 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2022 | 1185 | 0.110 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.110 |
Why?
|
Suicide | 1 | 2023 | 1477 | 0.110 |
Why?
|
Phosphorus | 3 | 2021 | 338 | 0.110 |
Why?
|
Body Height | 1 | 2018 | 1576 | 0.100 |
Why?
|
Choice Behavior | 1 | 2018 | 803 | 0.100 |
Why?
|
Child Abuse | 1 | 2020 | 1030 | 0.100 |
Why?
|
Educational Status | 3 | 2024 | 2539 | 0.100 |
Why?
|
Ethylene Glycol | 1 | 2011 | 29 | 0.100 |
Why?
|
Nursing Homes | 1 | 2018 | 1036 | 0.100 |
Why?
|
Body Mass Index | 2 | 2019 | 12718 | 0.100 |
Why?
|
Hormone Replacement Therapy | 2 | 2018 | 744 | 0.100 |
Why?
|
Bone Remodeling | 1 | 2014 | 575 | 0.100 |
Why?
|
Quality of Life | 2 | 2023 | 12805 | 0.090 |
Why?
|
Calcium | 2 | 2021 | 5757 | 0.090 |
Why?
|
Infant, Newborn | 2 | 2022 | 25618 | 0.090 |
Why?
|
Accidental Falls | 1 | 2018 | 1062 | 0.090 |
Why?
|
Monte Carlo Method | 2 | 2015 | 1254 | 0.090 |
Why?
|
Labor, Obstetric | 1 | 2013 | 333 | 0.090 |
Why?
|
Hip Fractures | 1 | 2018 | 955 | 0.090 |
Why?
|
Microarray Analysis | 2 | 2023 | 766 | 0.090 |
Why?
|
Myocardium | 1 | 2023 | 4776 | 0.090 |
Why?
|
Genetic Testing | 4 | 2023 | 3443 | 0.090 |
Why?
|
Anxiety | 2 | 2023 | 4297 | 0.090 |
Why?
|
Brain Injuries | 1 | 2021 | 2025 | 0.090 |
Why?
|
Organogenesis | 1 | 2011 | 222 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17449 | 0.090 |
Why?
|
Polychlorinated Biphenyls | 1 | 2011 | 245 | 0.090 |
Why?
|
Diagnostic Tests, Routine | 1 | 2015 | 783 | 0.080 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.080 |
Why?
|
Patient Readmission | 1 | 2023 | 3114 | 0.080 |
Why?
|
Rabbits | 1 | 2015 | 4892 | 0.080 |
Why?
|
Tibia | 1 | 2014 | 1077 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2355 | 0.080 |
Why?
|
Logistic Models | 2 | 2021 | 13409 | 0.080 |
Why?
|
ROC Curve | 2 | 2015 | 3527 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10250 | 0.080 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.080 |
Why?
|
Hippocampus | 1 | 2021 | 3676 | 0.080 |
Why?
|
Quality of Health Care | 1 | 2023 | 4371 | 0.080 |
Why?
|
Chronic Disease | 1 | 2022 | 9147 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2015 | 19907 | 0.070 |
Why?
|
Cohort Studies | 7 | 2023 | 40559 | 0.070 |
Why?
|
Syndrome | 2 | 2023 | 3250 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12355 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2023 | 63119 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8090 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2022 | 4259 | 0.070 |
Why?
|
Vaccines | 1 | 2014 | 822 | 0.070 |
Why?
|
Middle Aged | 10 | 2023 | 213367 | 0.070 |
Why?
|
Sexual Behavior | 1 | 2015 | 2056 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.060 |
Why?
|
Social Class | 2 | 2024 | 1999 | 0.060 |
Why?
|
Pregnancy | 4 | 2023 | 29142 | 0.060 |
Why?
|
Phenotype | 4 | 2023 | 16365 | 0.060 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3849 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2420 | 0.060 |
Why?
|
Monitoring, Physiologic | 2 | 2022 | 1737 | 0.060 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 1940 | 0.060 |
Why?
|
Osteoporosis | 1 | 2013 | 1580 | 0.060 |
Why?
|
Incidence | 1 | 2022 | 20945 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3336 | 0.060 |
Why?
|
Failure to Thrive | 1 | 2023 | 136 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 175 | 0.050 |
Why?
|
Porins | 1 | 2022 | 81 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2023 | 165 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2023 | 20817 | 0.050 |
Why?
|
Zambia | 1 | 2022 | 261 | 0.050 |
Why?
|
Entropy | 1 | 2022 | 209 | 0.050 |
Why?
|
Prospective Studies | 5 | 2023 | 53280 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2022 | 154 | 0.050 |
Why?
|
Ataxia | 1 | 2023 | 304 | 0.050 |
Why?
|
Mice, Inbred CBA | 1 | 2021 | 448 | 0.050 |
Why?
|
Bone Density | 1 | 2013 | 3468 | 0.050 |
Why?
|
Mice, 129 Strain | 1 | 2021 | 386 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2021 | 351 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2013 | 5021 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 387 | 0.040 |
Why?
|
HIV Infections | 2 | 2018 | 16718 | 0.040 |
Why?
|
Personality Inventory | 1 | 2023 | 1030 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2021 | 570 | 0.040 |
Why?
|
Calcitriol | 1 | 2021 | 298 | 0.040 |
Why?
|
Adult | 9 | 2024 | 214035 | 0.040 |
Why?
|
Area Under Curve | 2 | 2015 | 1655 | 0.040 |
Why?
|
School Health Services | 1 | 2023 | 375 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 441 | 0.040 |
Why?
|
Dementia | 1 | 2013 | 2518 | 0.040 |
Why?
|
Epilepsy, Generalized | 1 | 2021 | 174 | 0.040 |
Why?
|
Personality | 1 | 2023 | 552 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2023 | 12035 | 0.040 |
Why?
|
Virulence Factors | 1 | 2022 | 509 | 0.040 |
Why?
|
Nephrocalcinosis | 1 | 2018 | 48 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2023 | 737 | 0.040 |
Why?
|
Parents | 2 | 2023 | 3407 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2022 | 535 | 0.040 |
Why?
|
Young Adult | 4 | 2022 | 56436 | 0.040 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2018 | 55 | 0.040 |
Why?
|
Mutation | 4 | 2023 | 29784 | 0.040 |
Why?
|
Homozygote | 1 | 2023 | 1786 | 0.040 |
Why?
|
Mesocricetus | 1 | 2018 | 252 | 0.040 |
Why?
|
Japan | 1 | 2022 | 1361 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3508 | 0.040 |
Why?
|
Sex Factors | 2 | 2023 | 10396 | 0.040 |
Why?
|
Horse Diseases | 1 | 2018 | 57 | 0.040 |
Why?
|
Risk Factors | 2 | 2022 | 72280 | 0.040 |
Why?
|
Malformations of Cortical Development | 1 | 2020 | 200 | 0.040 |
Why?
|
Animals | 7 | 2022 | 168788 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2022 | 747 | 0.040 |
Why?
|
Horses | 1 | 2018 | 304 | 0.040 |
Why?
|
Vitamin D | 3 | 2018 | 3222 | 0.040 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2018 | 315 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14726 | 0.040 |
Why?
|
Time Factors | 4 | 2021 | 40063 | 0.040 |
Why?
|
Observation | 1 | 2019 | 312 | 0.040 |
Why?
|
Stress, Psychological | 2 | 2022 | 4245 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2011 | 4236 | 0.040 |
Why?
|
Species Specificity | 1 | 2021 | 2480 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1143 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2018 | 683 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2023 | 857 | 0.030 |
Why?
|
Homes for the Aged | 1 | 2018 | 260 | 0.030 |
Why?
|
Self-Injurious Behavior | 1 | 2021 | 465 | 0.030 |
Why?
|
Aging | 3 | 2022 | 8661 | 0.030 |
Why?
|
Parenting | 1 | 2022 | 679 | 0.030 |
Why?
|
Video Recording | 1 | 2021 | 947 | 0.030 |
Why?
|
Reward | 1 | 2022 | 941 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2021 | 1101 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3311 | 0.030 |
Why?
|
Haversian System | 1 | 2014 | 9 | 0.030 |
Why?
|
Cognition | 2 | 2023 | 6765 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
Attitude | 1 | 2020 | 774 | 0.030 |
Why?
|
Urban Population | 1 | 2023 | 2021 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 1953 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2121 | 0.030 |
Why?
|
Thinness | 1 | 2018 | 479 | 0.030 |
Why?
|
Diaphyses | 1 | 2014 | 65 | 0.030 |
Why?
|
Receptors, Nicotinic | 1 | 2018 | 497 | 0.030 |
Why?
|
Glycoproteins | 1 | 2022 | 2263 | 0.030 |
Why?
|
Cricetinae | 1 | 2018 | 2472 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2023 | 1637 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1854 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2015 | 513 | 0.030 |
Why?
|
Porosity | 1 | 2014 | 362 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1486 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2805 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21672 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1772 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2108 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1919 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2183 | 0.030 |
Why?
|
Family | 1 | 2023 | 3148 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2013 | 8037 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39045 | 0.030 |
Why?
|
Collagen Type I | 1 | 2014 | 592 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 428 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2023 | 1797 | 0.020 |
Why?
|
Heart Rate | 1 | 2022 | 4092 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13280 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2563 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2011 | 163 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2023 | 3297 | 0.020 |
Why?
|
Health Promotion | 1 | 2023 | 2205 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8343 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2213 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2011 | 665 | 0.020 |
Why?
|
Insulin Infusion Systems | 1 | 2011 | 212 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3598 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4188 | 0.020 |
Why?
|
Health Status | 1 | 2023 | 4034 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21824 | 0.020 |
Why?
|
Calcinosis | 1 | 2018 | 1499 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15538 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3023 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7303 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10387 | 0.020 |
Why?
|
Magnesium | 1 | 2011 | 813 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2011 | 317 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3063 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9311 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2014 | 2378 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57768 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6101 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6485 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3339 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2559 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2011 | 367 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5316 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1725 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4987 | 0.020 |
Why?
|
Overweight | 1 | 2018 | 2370 | 0.020 |
Why?
|
Femur | 1 | 2013 | 1297 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5615 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3674 | 0.020 |
Why?
|
Obesity | 2 | 2019 | 12742 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3313 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2078 | 0.020 |
Why?
|
Viral Load | 1 | 2013 | 3300 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81178 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18367 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4929 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4407 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 8302 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2013 | 3085 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29050 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2011 | 2796 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 6991 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12244 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14556 | 0.010 |
Why?
|
Rats | 1 | 2013 | 24273 | 0.010 |
Why?
|
Diet | 1 | 2013 | 7937 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35423 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2011 | 15294 | 0.010 |
Why?
|